|
|
|
|
Fibrogen Inc (NASDAQ: FGEN) |
|
|
|
| |
FGEN's Revenue Growth by Quarter and Year
Fibrogen Inc 's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| FGEN Revenue (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
| 4th Quarter |
December |
-
|
0.00
|
27.14
|
34.37
|
| 3rd Quarter |
September |
-
|
46.33
|
40.13
|
15.74
|
| 2nd Quarter |
June |
-
|
50.64
|
44.32
|
29.81
|
| 1st Quarter |
March |
2.74
|
55.90
|
36.16
|
60.83
|
| FY |
|
2.74
|
152.87
|
147.75
|
140.75
|
| FGEN Revenue first quarter 2025 Y/Y Growth Comment |
Fibrogen Inc reported drop in Revenue in the first quarter 2025 by -95.1% to $ 2.74 millions, from the same quarter in 2024.
The fall in the first quarter 2025 Fibrogen Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 15.38%.
Looking into first quarter 2025 results within Major Pharmaceutical Preparations industry 66 other companies have achieved higher Revenue growth. While Fibrogen Inc ' s Revenue meltdown of -95.1% ranks overall at the positon no. 640 in the first quarter 2025.
|
| FGEN Revenue ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
December |
- |
- |
-21.04 % |
107.8 % |
| 3rd Quarter |
September |
- |
15.45 % |
154.96 % |
-89.91 % |
| 2nd Quarter |
June |
- |
14.26 % |
48.67 % |
22.37 % |
| 1st Quarter |
March |
-95.1 % |
54.59 % |
-40.56 % |
58.29 % |
| FY |
|
- |
3.47 % |
4.97 % |
-40.18 % |
FGEN Revenue (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
December |
- |
- |
-32.37 % |
118.36 % |
| 3rd Quarter |
September |
- |
-8.51 % |
-9.45 % |
-47.2 % |
| 2nd Quarter |
June |
- |
-9.41 % |
22.57 % |
-50.99 % |
| 1st Quarter |
March |
- |
105.97 % |
5.21 % |
267.78 % |
| FY (Year on Year) |
|
- |
3.47 % |
4.97 % |
-40.18 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 142.35 % |
15.38 % |
-69.24 % |
| (Sep 30 2021) |
|
(Jun 30 2020) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 142.35 % |
15.38 % |
-69.24 % |
| (Sep 30 2021) |
|
(Jun 30 2020) |
|
| Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Fibrogen Inc 's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| FGEN's I. Quarter Q/Q Revenue Comment |
|
|
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| FGEN's I. Quarter Q/Q Revenue Comment |
|
|
|
Fibrogen Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Mar 31 2025) |
12 Months Ending
(Dec 31 2024) |
12 Months Ending
(Sep 30 2024) |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
| Cumulative Revenue 12 Months Ending |
$ 0.00 |
$ 0.00 |
$ 180.01 |
$ 173.82 |
$ 167.49 |
| Y / Y Revenue Growth (TTM) |
- |
- |
16.15 % |
33.11 % |
44.31 % |
| Year on Year Revenue Growth Overall
Ranking |
# 227 |
# 1580 |
# 365 |
# 3416 |
# 0 |
| Seqeuential Revenue Change (TTM) |
- |
- |
3.57 % |
3.77 % |
13.36 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 808 |
# 2570 |
# 630 |
# 930 |
# 0 |
| Cumulative Revenue growth Comment |
Fibrogen Inc realized trailing twelve months of $ 0 millions, in the Mar 31 2025, compare to Revenue of $ 167 millions a year ago.
In the Healthcare sector 64 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 227, from total ranking in previous quarter at 1580. |
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
142.35 % |
15.38 % |
-69.24 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 73 |
| Sector |
# 180 |
| S&P 500 |
# 808 |
|
| Cumulative Revenue growth
Comment |
Fibrogen Inc realized trailing twelve months of $ 0 millions, in the Mar 31 2025, compare to Revenue of $ 167 millions a year ago.
In the Healthcare sector 64 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 227, from total ranking in previous quarter at 1580. |
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
142.35 % |
15.38 % |
-69.24 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 73 |
| Sector |
# 180 |
| S&P 500 |
# 808 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
